BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
76.30
+2.16 (2.91%)
At close: Dec 19, 2025, 4:00 PM EST
76.30
0.00 (0.00%)
After-hours: Dec 19, 2025, 7:59 PM EST
BridgeBio Pharma Analyst Ratings
Total Analysts
21
Consensus Rating
Strong Buy
Price Target
$76.24
Upside
-0.08%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Maintains $75 → $86 | Buy | Maintains | $75 → $86 | +12.71% | Dec 15, 2025 |
| Bernstein | Bernstein | Buy Initiates $94 | Buy | Initiates | $94 | +23.20% | Dec 11, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $76 → $84 | Buy | Maintains | $76 → $84 | +10.09% | Nov 11, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $76 → $77 | Buy | Maintains | $76 → $77 | +0.92% | Nov 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +17.96% | Nov 3, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $55 → $100 | Strong Buy | Maintains | $55 → $100 | +31.06% | Oct 31, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $60 → $95 | Strong Buy | Maintains | $60 → $95 | +24.51% | Oct 30, 2025 |
| Raymond James | Raymond James | Buy Reiterates $69 → $71 | Buy | Reiterates | $69 → $71 | -6.95% | Oct 30, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $100 → $110 | Buy | Maintains | $100 → $110 | +44.17% | Oct 30, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $93 → $98 | Buy | Maintains | $93 → $98 | +28.44% | Oct 30, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $66 → $80 | Strong Buy | Reiterates | $66 → $80 | +4.85% | Oct 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $90 | Strong Buy | Maintains | $80 → $90 | +17.96% | Oct 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $70 → $80 | Strong Buy | Maintains | $70 → $80 | +4.85% | Oct 27, 2025 |
| Raymond James | Raymond James | Buy Maintains $56 → $59 | Buy | Maintains | $56 → $59 | -22.67% | Oct 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $70 | Strong Buy | Reiterates | $70 | -8.26% | Sep 15, 2025 |
| UBS | UBS | Strong Buy Maintains $72 → $82 | Strong Buy | Maintains | $72 → $82 | +7.47% | Sep 12, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.